Technology has advanced to allow for efficient testing of an individual’s genetics relative to treatment response. Application of pharmacogenomics (PGx) testing across therapeutic areas can lead to more optimized drug therapy, increasing efficacy while decreasing or avoiding adverse drug reactions in patients. The positive impact of PGx on costs is realized at the patient and system levels, supporting broader implementation of PGx services.
This white paper from LetsGetChecked discusses PGx testing, why and when it should be performed, disease areas that could benefit from PGx testing, evidence supporting testing, and cost savings afforded by PGx.
Offered Free by: LetsGetChecked
See All Resources from: LetsGetChecked